Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

Iovance Biotherapeutics, Inc. bouchon mache

Volim nan komès stock Iovance Biotherapeutics, Inc. jodi a ak istwa a nan lèt majiskil nan Iovance Biotherapeutics, Inc. Depi nan kòmansman an nan komès nan IOVA aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

Iovance Biotherapeutics, Inc. lèt majiskil

Jodi a lèt majiskil sou mache a nan Iovance Biotherapeutics, Inc. se 1 452 494 080 US dola.
-17 794 688 $ (-1.21%)
chanjman nan lèt majiskil depi yè

Iovance Biotherapeutics, Inc. kapitalize mache an dola jodi a. Chak jou, nou anrejistre yon chanjman nan majiskil Iovance Biotherapeutics, Inc.. Baze sou komès nan stock stock Iovance Biotherapeutics, Inc. sou mache dechanj, ou ka evalye lèt majiskil nan Iovance Biotherapeutics, Inc.. Iovance Biotherapeutics, Inc., majiskil - 1 452 494 080 dola ameriken.

Iovance Biotherapeutics, Inc. volim nan komès

Jodi a volim nan komès de aksyon Iovance Biotherapeutics, Inc. montan 172 745 US dola.
-2 239 440 $ (-92.84%)
chanjman nan volim nan komès depi yè

Iovance Biotherapeutics, Inc. komès komès jodi a totalize $ 172 745. Jodi a, Iovance Biotherapeutics, Inc. komès te pran plas sou mache aksyon divès kalite. Iovance Biotherapeutics, Inc. komès sou entènèt ki te fèt sou pifò echanj machandiz sou entènèt, sit entènèt nou an montre total komès volim Iovance Biotherapeutics, Inc. pou chak jou. Iovance Biotherapeutics, Inc. majiskil diminye konpare ak yè.

Montre:
Pou

Iovance Biotherapeutics, Inc. mache bouchon tablo

Iovance Biotherapeutics, Inc. majiskil sou yon graf pa ane. 18.94% - yon chanjman nan lèt majiskil sou mache Iovance Biotherapeutics, Inc. pou chak semèn. 0% chak mwa - yon chanjman nan lèt majiskil sou mache Iovance Biotherapeutics, Inc.. Iovance Biotherapeutics, Inc., majiskil kounye a - 1 452 494 080 dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

Iovance Biotherapeutics, Inc. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
04/05/2023 1 452 494 080 $
03/05/2023 1 470 288 768 $
02/05/2023 1 397 997 696 $
01/05/2023 1 440 260 096 $
28/04/2023 1 261 200 768 $
27/04/2023 1 220 050 560 $
26/04/2023 1 221 162 624 $

Iovance Biotherapeutics, Inc. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

Iovance Biotherapeutics, Inc. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon Iovance Biotherapeutics, Inc. se kantite total tout tranzaksyon ak aksyon IOVA achte ak vann pandan dat la chwazi a.
04/05/2023 172 745 $
03/05/2023 2 412 185 $
02/05/2023 712 190 $
01/05/2023 7 010 007 $
28/04/2023 1 482 595 $
27/04/2023 72 144 $
26/04/2023 963 462 $

Iovance Biotherapeutics, Inc. mache majiskil nan 04/05/2023 egal a 1 452 494 080 dola ameriken. Iovance Biotherapeutics, Inc. mache majiskil nan 03/05/2023 egal a 1 470 288 768 dola ameriken. Iovance Biotherapeutics, Inc. mache majiskil nan 02/05/2023 egal a 1 397 997 696 dola ameriken. Sou 01/05/2023, Iovance Biotherapeutics, Inc. lèt majiskil mache a te $ 1 440 260 096.

28/04/2023 Iovance Biotherapeutics, Inc. lèt majiskil mache egal a 1 261 200 768 dola ameriken. 27/04/2023 Iovance Biotherapeutics, Inc. majiskil egal a 1 220 050 560 dola ameriken. 26/04/2023 Iovance Biotherapeutics, Inc. majiskil montan pou 1 221 162 624 dola ameriken.

Lèt majiskil Iovance Biotherapeutics, Inc. jodi a se 1 452 494 080 $. Kapitalizasyon sou mache a nan Iovance Biotherapeutics, Inc. te chanje a -1.21% konpare ak yè. Volim komèsyal de aksyon IOVA nan Iovance Biotherapeutics, Inc. nan dènye jou komès montan pou 172 745 $. Volim komèsyal de aksyon de Iovance Biotherapeutics, Inc. chanje pou -92.839% konpare ak jou komès anvan an.

Pri a de aksyon Iovance Biotherapeutics, Inc.

Finans Iovance Biotherapeutics, Inc.